Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
40.5M
-
Shares change
-
+2.26M
-
Total reported value, excl. options
-
$1.91B
-
Value change
-
+$122M
-
Put/Call ratio
-
0.62
-
Number of buys
-
99
-
Number of sells
-
-64
-
Price
-
$47.04
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2018
207 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2018.
REPLIGEN CORP - COMMON STOCK (RGEN) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.5M shares
of 56.2M outstanding shares and own 72.07% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.85M shares), VANGUARD GROUP INC (3.06M shares), OppenheimerFunds, Inc. (2.14M shares), TimesSquare Capital Management, LLC (2.08M shares), Invesco Ltd. (2.03M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.81M shares), STATE STREET CORP (1.75M shares), Conestoga Capital Advisors, LLC (1.71M shares), MACQUARIE GROUP LTD (1.11M shares), and DIMENSIONAL FUND ADVISORS LP (1.02M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.